Plain-English translation of NCT06851663 on ClinicalTrials.gov โ ยท Source last updated ยท Translation generated ยท How we translate trials
Phase 3 โ Testing in thousands of people, comparing the treatment against what doctors currently use. This is the last big step before approval.
This trial is testing a new type of imaging scan called Trop2-targeted immunoPET that may help doctors better detect and monitor solid cancers. The scan uses a special tracer (a small radioactive marker) that highlights cancer cells in your body. Researchers want to see if this new imaging approach works better than current standard imaging methods for detecting cancers in different parts of the body.
Current cancer imaging methods like standard PET scans don't always give doctors the clearest picture of where cancer is located or how it's responding to treatment. This trial exists to see whether the new imaging approach can provide more accurate information to help doctors diagnose and monitor cancers more effectively.
You likely qualify ifโฆ
You likely don't qualify ifโฆ
If you enroll, you will receive an injection of a small amount of radioactive tracer and then return for a full-body imaging scan (called a PET/CT scan) about 1โ2 hours later. The scan itself takes less than an hour and is painless. Researchers will measure how much of the tracer your cancer cells take up and compare the results to standard imaging and any tissue samples you may have had. You may also be part of the follow-up group if you're being monitored for cancer recurrence or treatment response.
AI-generated summary from trial data ยท Jun 7, 2026 ยท Not medical advice
China
Phase
Large-scale testing
Sponsor
RenJi Hospital
Enrollment target
~400 participants
Started
December 2024
Primary completion
December 2027
Age range
18 Years โ 75 Years
Last updated on clinicaltrials.gov in May 2026.
Reach out to the team running this trial. Response times vary โ some teams are faster than others.
Central contact
Weijun Wei, Ph.D. & M.D.
Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first โ no email needed to get started.